Moreover, adiponectin levels were inversely related to serum IGF-1 in acromegaly, suggesting that both IGF-1 and BMI are determinant factors affecting circulating adiponectin levels in patients with active disease. This evidence concerns the gene ADIPOQ and acromegaly.